节点文献

血管紧张素转化酶基因多态性与依那普利降压疗效的相关性研究

Study on the relationship between the therapeutic effect of enalapril on blood pressure reduction and ACE genetic polymorphisms

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 唐强; 黄友良; 俞群军; 黄琼; 尹继业; 周宏灏; 刘昭前;

【Author】 TANG Qiang1,HUANG You-liang1,YU Qun-jun1,HUANG Qiong2,YIN Ji-ye2,ZHOU Hong-hao2,LIU Zhao-qian21Affiliated Third Hospital of Huaihua Medical Training School,Huaihua 418000,Hunan,China;2Institute of Clinical Pharmacology,Hunan Key Laboratory of Pharmacogenetics,Central South University,Changsha 410078,Hunan, China

【机构】 怀化医学高等专科学校附属怀化市第三人民医院; 中南大学临床药理研究所,遗传药理学湖南省重点实验室; 中南大学临床药理研究所遗传药理学湖南省重点实验室;

【摘要】 目的:研究血管紧张素转化酶(angiotensin-converting enzyme,ACE)基因多态性与依那普利降压疗效的相关性。方法:采用聚合酶链式反应-限制性片断长度多态性(polymerase chain reaction-re-striction fragment length polymorphism,PCR-RFLP)对68例原发性高血压患者进行ACE基因型分析,根据ACE三种基因型DD型、ID型和II型将受试者分为三组,所有受试者每天服用依那普利20 mg进行2周的降压治疗,观察依那普利在三种不同ACE基因型中的降压疗效及差异。结果:在所有68例原发性高血压患者中,依那普利治疗前与治疗后每组SBP和DBP的降低均有统计学意义(P<0.05),其中DD型与II型两组之间的SBP和DBP降压幅度(即治疗前与治疗后血压的差值)有统计学意义(P<0.05)。DD型组依那普利的总有效率为91.30%,ID型组为85.71%,II型组是79.16%。结论:原发性高血压患者中ACE基因多态性与依那普利降压疗效相关。

【Abstract】 AIM: To investigate the relationship between the therapeutic effect of enalapril on blood pressure reduction and ACE genetic polymorphisms.METHODS: The genotypes of ACE in 68 patients with essential hypertension were determined by polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) assay.All subjects were randomly divided into three groups(group DD,group II,and group ID) according to their different ACE genotypes.68 patients with essential hypertension were treated with 20 mg enalapril daily for 2 consecutive weeks.The changes of systolic and diastolic blood pressure in all subjects were observed before and after enalapril administration.RESULTS: The data showed that there were significantly statistical difference in the systolic blood pressure and diastolic blood pressure in three groups’ patients with essential hypertension between before and after enalapril administration(P<0.05).Additionally,there was marked difference in the differential values of systolic blood pressure and diastolic blood pressure reduction between group DD and group II(P<0.05).The total efficacy rate of enalapril treatment was 91.30% in group DD,85.71% in group ID,and 79.16% in group II respectively,which indicated enalapril had the best effect on blood pressure reduction in DD genotyped group.CONCLUSION: The therapeutic effect of enalapril on blood pressure reduction is associated with ACE genetic polymorphism and the essential hypertensive patients with DD genotypes had the best response to enalapril treatment compared with ID genotypes and II genotypes.

【基金】 国家自然科学基金项目(30572230);湖南省自然科学基金重点项目(08JJ3058)
  • 【文献出处】 中国临床药理学与治疗学 ,Chinese Journal of Clinical Pharmacology and Therapeutics , 编辑部邮箱 ,2009年01期
  • 【分类号】R544.1
  • 【被引频次】9
  • 【下载频次】329
节点文献中: 

本文链接的文献网络图示:

本文的引文网络